Navigation Links
Senesco's Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics'
Date:10/20/2008

tnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products.

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors, including, but not limited to: the development of the Company's gene technology; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs and joint ventures; the success of the Company's license agreements; the acceptance by the market of the Company's products; success of the Company's preliminary studies and preclinical research; competition and the timing of projects and trends in future operating performance, our ability to maintain our continued listing standards for the next 12 months, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Company Contacts: Investor Relations Contact:

Senesco Technologies, Inc. FD

Bruce Galton Brian Ritchie

Chief Executive Officer (brian.ritchie@fd.com)

(bgalton@senesco.com) (212) 850-5600

(732) 296-8400


'/>"/>
SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genmab Announces Encouraging Preclinical Data for ofatumumab
2. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
3. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
4. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
5. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
6. Arpida Presents Preclinical Data on AR-2474 at ICAAC
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
9. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
10. Preclinical Efficacy Data Demonstrate Ability of Tengions Neo-Bladder Augment to Restore Bladder Function
11. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...GHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma and b...lution. The companies are facing significant,pres...ng R&D costs, calls for,lower prices and a gre...with,the financial crisis have made the work of cr...cal companies are being forced to globalize their ...
(Date:11/9/2009)... Product release is a research industry...earch facilities and research safety study data to... Cedar Knolls, NJ (PRWEB) Novembe...y that it has unveiled Pristima™ VM, an inte...acilities that track the use and care of veterinar...
(Date:11/7/2009)...E, Mass., Nov. 7, Research project...red top marks this evening, as Tim Kunisky of Livi...(Jack) Chen of Audubon, PA received the highest ho... Competition in Math, Science & Technology, th.... ,, ( http://www.newscom.com/cgi-bin/prnh/200...
(Date:11/6/2009)...Mass., Nov. 6 Myriant Technologies...per and manufacturer of renewable bio-chemicals, ...nology provider Uhde GmbH, one of the world,s lead...unced an alliance for the engineering, procurement...ccinic Acid plants based on renewable feedstocks. ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3
..., March 28 Pharmasset, Inc.,(Nasdaq: VRUS ) rece...hnology Finance under an existing working capital ...ber 2007. Pharmasset received the first loan,of $1...receive a third loan,of $10 million by November 30..., "We believe that our existing cash resources, t...
...March 28 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ...ent of,compounds for the treatment of cardiovascul...SDAQ Marketplace Rule 4350(b)(1)(B), that the inde...ual Report on Form 10-K for the,fiscal year ended ...d,Exchange Commission on March 28, 2008 contained ...
...tform offers multiple diagnostic modalities on a s...e for the first time to physic...cano Corporation,(Nasdaq: VOLC ), a leading manuf...(IVUS), functional measurement (FM) and Optical Co...nce the diagnosis and treatment,of coronary and pe...
Other Biology Technology:Pharmasset Receives $10 Million of Working Capital 2Pharmasset Receives $10 Million of Working Capital 3VIA Pharmaceuticals Complies With NASDAQ Rule 2VIA Pharmaceuticals Complies With NASDAQ Rule 3Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 2Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 3Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 4Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 5
(Date:11/9/2009)...udies conducted in California and elsewhere provid... for managing fisheries and protecting marine habi... California, Santa Cruz. , A recent study in th...alidity of a key concept behind marine reserves--t...a can replenish the stocks of harvested species ou...
(Date:11/9/2009)...ny marine plants called phytoplankton are flourish...ent and rapid melting of ice shelves and glaciers ...lonisation is having a beneficial impact on climat...ks to the sea-bed where it can store carbon for th...week in the journal Global Change Biology , scien...
(Date:11/9/2009)..., N.Y. Oncologists have had their hands tied beca...ions that disable a protein called p53. As a criti...cancer-fighting operations within cells. When cell...not be treated. , These tumors might be tough, ...rom Cold Spring Harbor Laboratory (CSHL). The chin...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5Antarctica glacier retreat creates new carbon dioxide store 2CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3Drug proof zebrafish reveal secrets of addiction 9448 1Drug proof zebrafish reveal secrets of addiction 9448 2Knights of Columbus Gather in Phoenix for 127th International Convention 53400 1Knights of Columbus Gather in Phoenix for 127th International Convention 53400 2AIDS patients face higher risk of HPV related cancers as immunosuppression grows 53397 1AIDS patients face higher risk of HPV related cancers as immunosuppression grows 53397 2
...pecially food and beverage products, are being scr...Missouri-Columbia, a food science expert has devel...ensure fruit and vegetable juice products adhere t...ollaborating with scientists in the United States ...professor of food science in the College of Agricu...
...rtance nowadays since it express who we are, but i...ividual from its form? The answer to that question... group of scientists from the Universidad Nacional...USA, were able to address it, although motivated b...apacity to establish the function of a molecule, p...
...lth Organisation (WHO) has confirmed a low frequen...nfluenza seasons (2003 ?2006)1. , The informati...ptibility Network in the WHO’s Weekly Epidemiologi...0.3% to oseltamivir was seen during the influenza ...lu use in Japan (35 million patients), the highest...
Other Biology News:New bacteria test could improve quality of fruit and vegetable juice 2WHO data confirms low level of resistance to Tamiflu 2WHO data confirms low level of resistance to Tamiflu 3
MBS Thermal Cycler 2 Block Laptop Kit from Thermo Scientific
...ctive drives of VARIOMAG Magnetic Stirrers operate...r mechanical bearings, making VARIOMAG Magnetic St...ition, the VARIOMAG inductive drive can be hermeti...t or microorganisms. This is why VARIOMAG Magnetic...
...c method stops PCR carry-over contamination, which...ade PCR products from previous PCR amplifications ...hich improves amplification ,Optimized for use wit... systems , The GeneAmp PCR Carry-over Prevention ...
...Class II safety cabinets Heraeus HERAsafe KS convi...and user-orientated design. ,The new frameless sl... area. The new front window design makes it easy t...re with a height of more than 250 mm ensures ease ...
Biology Products: